CAR T Cell Therapy Treatment for Non-Hodgkin's Lymphoma

CAR T cell therapy is a new FDA approved immunotherapy for treating non-Hodgkin's lymphoma. Dr. Gwen Nichols, chief medical officer of the Leukemia & Lymphoma Society, explains CAR T's applications, process, and history as a cancer therapy. Read about an NHL survivor who credits CAR T cell therapy with his positive outcomes.